UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 1418, 2025

WRAP TECHNOLOGIES, INC.

(Exact name of ~~registrant~~Registrant as specified in its ~~charter~~Charter)

Delaware		001-38750		98-0551945
(State or other jurisdiction of incorporation)		(Commission File ~~Number~~No.)		(IRS Employer Identification No.)

3480 Main Hwy, Suite 202, Miami, Florida 33133

~~Miami,~~(Address ~~Florida~~of ~~33133~~principal executive offices) (Zip code)

(Address of principal executive offices) (Zip Code)

(800) 583-2652

(Registrant’s ~~telephone~~Telephone ~~number, including area code~~Number)

Not Applicable

(Former name or ~~former~~ address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		WRAP		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) ☐

~~Emerging~~If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

IfItem an1.01. ~~emerging~~Entry ~~growth~~into company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) ofMaterial ~~the~~Definitive ~~Exchange Act~~Agreement. ☐

~~Item~~Securities ~~2.02~~Purchase ~~Results of Operations and Financial Condition.~~Agreement

On August 1418, 2025, Wrap Technologies, Inc. (the “Company”) ~~issued~~entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of an ~~earnings~~aggregate ~~release~~of to(i) ~~announce~~4,500 shares of the Company’s ~~financial~~newly-designated Series ~~results~~B ~~for~~Convertible ~~its~~Preferred ~~fiscal~~Stock, ~~quarter~~with ~~ended~~a ~~June~~par 30value of $0.0001 per share and a stated value of $1,000 ~~2025~~per share, initially convertible into up to 3,000,000 shares of the Company’s common stock, par value $0.0001 Aper ~~copy~~share (“Common Stock”), at an initial conversion price of $1.50 per share (the ~~earnings~~“Preferred ~~release~~Stock”), isand ~~attached~~(ii) accompanying warrants (“Warrants”) to ~~this~~purchase up ~~Current~~to ~~Report~~3,000,000 shares of Common Stock, with an initial exercise price of $1.50 per share. The Warrants and the shares of Preferred Stock will be exercisable or convertible, respectively, into shares of Common Stock beginning on ~~Form~~the ~~8-K~~effective asdate of stockholder approval ~~Exhibit~~of (i) under Nasdaq Stock Market Rule 5635(d), the issuance of shares of Common Stock in excess of 19.99% of the Company’s issued and outstanding shares of Common Stock at prices below the “Minimum Price” (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of the Purchase Agreement pursuant to the terms of the Preferred Stock and the Warrants, and (ii) an increase in the authorized shares of the Company (the “Stockholder Approval”).1 The Warrants will expire five years from the effective date of the Stockholder Approval.

The ~~information~~Private inPlacement ~~this~~is ~~Current~~exempt ~~Report~~from onthe ~~Form~~registration ~~8-K,~~requirements ~~including~~of the ~~information~~Securities ~~set~~Act ~~forth~~of in1933, ~~Exhibit~~as ~~99.1~~amended (the “Securities Act”), pursuant isto ~~being~~the ~~furnished~~exemption ~~and~~for ~~shall~~transactions by an issuer not be ~~deemed~~involving ~~“filed”~~any ~~for~~public ~~purposes~~offering ofunder Section 184(a)(2) of the Securities ~~Exchange~~ Act and Rule 506 of ~~1934,~~Regulation asD ~~amended~~of (the ~~“Exchange~~Securities Act~~”), nor~~ ~~shall~~and ~~any~~in ~~exhibit~~reliance ~~filed~~on ~~herewith~~similar beexemptions ~~deemed~~under ~~incorporated~~applicable bystate ~~reference~~laws. inEach ~~any~~of ~~filing~~the ~~under~~Investors has represented to the ~~Securities~~Company ~~Act~~that it is an accredited investor within the meaning of ~~1933,~~Rule as501(a) ~~amended,~~of Regulation D and that it is acquiring the applicable securities for investment only and not with a view towards, or ~~the~~for ~~Exchange~~resale ~~Act~~in connection with, ~~except~~the aspublic ~~shall~~sale beor ~~expressly~~distribution thereof. ~~set~~The ~~forth~~Preferred byStock ~~specific~~and ~~reference~~Warrants inwere ~~such~~offered aand ~~filing~~sold without any general solicitation by the Company or its representatives.

The closing of the Private Placement is expected to occur on August 19, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds to the Company from the Private Placement are expected to be approximately $4.5 million, before estimated offering expenses payable by the Company. The Company intends to use the net proceeds received from the Private Placement for general corporate purposes and working capital.

The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Purchasers, including for liabilities under the Securities Act and other obligations of the parties and termination provisions. Among other covenants, the Purchase Agreement requires the Company to hold a meeting of its stockholders at the earliest practical date for the purpose of obtaining such Stockholder Approval. If the Company does not obtain the Stockholder Approval at the first meeting, the Company is required call a meeting every sixty (60) days thereafter to seek such Stockholder Approval until the earlier of the date Stockholder Approval is obtained or the shares of Preferred Stock are no longer outstanding.

Preferred Stock

The terms of the Preferred Stock are as set forth in the form of Certificate of Designations, attached hereto as Exhibit 3.1 to this Current Report on Form 8-K (the “Certificate of Designations”), which will be filed with the Secretary of State for the State of Delaware prior to the closing of the Private Placement. The Preferred Stock are convertible into the Conversion Shares at the election of the holders of the Preferred Stock (the “Holders”) at any time at an initial conversion price of $1.50 per share (the “Conversion Price”). The Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like (subject to certain exceptions).

Holders of the Preferred Stock shall be entitled to receive dividends when and as declared by the board of directors of the Company (the “Board”), from time to time, in its sole discretion, which dividends will be paid by the Company out of funds legally available therefor, payable, subject to the conditions and other terms of the Certificate of Designations, in cash, in securities of the Corporation or using assets as determined by the Board on the stated value of such Preferred Stock.

Except as otherwise provided in the Certificate of Designations or as otherwise required by law, the Preferred Stock has no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend the Certificate of Designations, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

There is no established public trading market for the Preferred Stock and the Company does not intend to list the Preferred Stock on any national securities exchange or nationally recognized trading system.

Warrants

A holder of the Warrants may not exercise any portion of such holder’s Warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise.

There is no established public trading market for the Warrants and the Company does not intend to list the Warrants on any national securities exchange or nationally recognized trading system.

Registration Rights Agreement

In connection with the Private Placement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”), dated as of August 18, 2025, with the Purchasers, pursuant to which the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the Common Shares and shares of Common Stock underlying the Warrants no later than 60 days following the date of the Registration Rights Agreement, and to use best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 90 days following the date of the Registration Rights Agreement (or 120 days following the date of the Registration Rights Agreement in the event of a “full review” by the SEC).

The foregoing descriptions of terms and conditions of the Certificate of Designations, Purchase Agreement, the Registration Rights Agreement and the Warrant do not purport to be complete and are qualified in their entirety by the full text of the Purchase Agreement, the Registration Rights Agreement, and Warrant, forms of which are attached hereto as Exhibits 3.1, 10.1, 10.2 and 4.1, respectively.

Item 3.02 Unregistered Sales of Equity Securities.

The matters described in Item 1.01 of this Current Report on Form 8-K related to the Private Placement are incorporated herein by reference. In connection with the issuance of the Preferred Stock and Warrants in the Private Placement described in Item 1.01, the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transactions not involving a public offering.

This report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 8.01 Other Events.

On August 18, 2025, the Company issued a press release announcing the Private Placement. A copy of the press release is attached as Exhibit 99.1 hereto.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press release dated August 14, 2025
3.1		Form of Certificate of Designations of Series B Convertible Preferred Stock.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)
4.1		Form of Warrant.
10.1*		Securities Purchase Agreement, dated August 18, 2025, by and among the Company and the investors signatory thereto.
10.2*		Registration Rights Agreement, dated August 18, 2025, by and among the Company and the investors signatory thereto.
99.1		Press Release, dated August 18, 2025.
104		Cover Page Interactive Data File (formatted as Inline XBRL)

* Certain of the schedules (and similar attachments) to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K under the Securities Act because they do not contain information material to an investment or voting decision and that information is not otherwise disclosed in the exhibit or the disclosure document. The registrant hereby agrees to furnish a copy of all omitted schedules (or similar attachments) to the SEC upon its request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	WRAP TECHNOLOGIES, INC.
Date: August 14, 2025.	By:	/s/ Jerry Ratigan
Date: August 18, 2025	By:	/s/ Scot Cohen
		Jerry Ratigan
		Scot Cohen
		Chief Financial Officer and Chief Accounting Officer
		Chief Executive Officer and Chairman of the Board

Filing Compare · WRAP TECHNOLOGIES, INC.